These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 10760796

  • 21. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
    Kim JW, Wieckowski E, Taylor DD, Reichert TE, Watkins S, Whiteside TL.
    Clin Cancer Res; 2005 Feb 01; 11(3):1010-20. PubMed ID: 15709166
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Lipopolysaccharide induces expression of APO2 ligand/TRAIL in human monocytes and macrophages.
    Halaas O, Vik R, Ashkenazi A, Espevik T.
    Scand J Immunol; 2000 Mar 01; 51(3):244-50. PubMed ID: 10736093
    [Abstract] [Full Text] [Related]

  • 25. Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells.
    Martínez-Lorenzo MJ, Alava MA, Anel A, Piñeiro A, Naval J.
    Immunology; 1996 Dec 01; 89(4):511-7. PubMed ID: 9014814
    [Abstract] [Full Text] [Related]

  • 26. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
    He Q, Luo X, Huang Y, Sheikh MS.
    Oncogene; 2002 Sep 05; 21(39):6032-40. PubMed ID: 12203115
    [Abstract] [Full Text] [Related]

  • 27. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
    Ray S, Almasan A.
    Cancer Res; 2003 Aug 01; 63(15):4713-23. PubMed ID: 12907654
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R, Bedi A.
    Cancer Res; 2002 Aug 01; 62(15):4180-5. PubMed ID: 12154014
    [Abstract] [Full Text] [Related]

  • 31. Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus.
    Tsai HF, Lai JJ, Chou AH, Wang TF, Wu CS, Hsu PN.
    Arthritis Rheum; 2004 Feb 01; 50(2):629-39. PubMed ID: 14872508
    [Abstract] [Full Text] [Related]

  • 32. Lipid raft assembly and Lck recruitment in TRAIL costimulation mediates NF-κB activation and T cell proliferation.
    Huang SC, Tsai HF, Tzeng HT, Liao HJ, Hsu PN.
    J Immunol; 2011 Jan 15; 186(2):931-9. PubMed ID: 21160038
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule.
    Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B, Tschopp J.
    Nat Immunol; 2000 Dec 15; 1(6):489-95. PubMed ID: 11101870
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Proteasome inhibitor MG132 upregulates death receptor 5 and cooperates with Apo2L/TRAIL to induce apoptosis in Bax-proficient and -deficient cells.
    He Q, Huang Y, Sheikh MS.
    Oncogene; 2004 Apr 01; 23(14):2554-8. PubMed ID: 14691451
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Butyric acid-induced T-cell apoptosis is mediated by caspase-8 and -9 activation in a Fas-independent manner.
    Kurita-Ochiai T, Ochiai K, Fukushima K.
    Clin Diagn Lab Immunol; 2001 Mar 01; 8(2):325-32. PubMed ID: 11238216
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.